Royalty Pharma to donate $7.5 million to expand therapy program
Royalty Pharma announced a $7.5 million donation to Blood Cancer United to support its Therapy Acceleration Program (TAP).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.